Showing results (231-240 of 1,113) with videos related to
Sort By:
Pageof 112
Value in Health Regional Issues|March 26, 2026
Cost-Utility Analysis of the Treatment With Ataluren Plus Standard of Care Compared With Standard of Care Alone in Patients With Duchenne Muscular Dystrophy in BrazilEliane W Roesch, Verônica Colpani, Grace Anne A Dória, et al.Value in Health Regional Issues|March 27, 2026
Assessment of Quality of Life Among Chronic Heart Failure Outpatients in Malaysia: Propensity Score Matched Analysis Between Self- and Proxy-Reports in 6 Health DimensionsYi Jing Tan, Siew Chin OngValue in Health Regional Issues|May 9, 2024
Quality of Life in Transfusion-Dependent Thalassemia Patients in Greece Before and During the COVID-19 PandemicPhilippos Klonizakis, Robert J Klaassen, Noémi Roy, et al.Value in Health Regional Issues|May 10, 2024
Mortalidad, Secuelas Clínicas y Calidad de Vida Luego del Alta de Unidades de Cuidados Intensivos en Pacientes con COVID-19: Estudio Multicéntrico Descriptivo en ArgentinaFernando Argento, Manuel Donato, Dario Villalba, et al.Value in Health Regional Issues|April 27, 2024
Tiered Pricing and Alternative Mechanisms for Equitative Access to Vaccines in Latin America: A Narrative Review of the LiteratureAdriana Arango-Luque, Daniela Yucumá, Camilo E Castañeda, et al.Value in Health Regional Issues|March 25, 2026
Health Technology Assessment in the MENA Region: A Scoping Review and Experts' Meeting SummaryAhmad Aljedai, Hajer Almudaihem, Anas Hamad, et al.Value in Health Regional Issues|April 24, 2026
Transferability of Patient Selection Model for Proton Radiation Therapy to Lower-Income European CountriesBertalan Németh, Diana Delnoij, Saskia Knies, et al.Value in Health Regional Issues|June 17, 2026
Patient Preferences for Lipid-Lowering Agents in Hypercholesterolemia: A Discrete Choice ExperimentHei Hang Edmund Yiu, Vincent Ka Chun Yan, Cheri Cheuk Lam Au, et al.Value in Health Regional Issues|January 5, 2024
Cost-Effectiveness of Onasemnogene Abeparvovec Compared With Nusinersen and Risdiplam in Patients With Spinal Muscular Atrophy Type 1 in Brazil: Custo-Efetividade do Onasemnogeno Abeparvoveque (AVXS-101) em Comparação ao Nusinersena e Risdiplam em Pacientes com Atrofia Muscular Espinhal Tipo 1 no BrasilBrígida Dias Fernandes, Fernanda D'Athayde Rodrigues, Hérica Núbia Cardoso Cirilo, et al.Value in Health Regional Issues|August 28, 2018
Activity-Based Costing and Time-Driven Activity-Based Costing for Assessing the Costs of Cancer Prevention, Diagnosis, and Treatment: A Systematic Review of the LiteratureRafael J Vargas Alves, Ana P Beck da Silva Etges, Giácomo Balbinotto Neto, et al.Pageof 112